Results 1 to 10 of about 8,266,744 (203)

Lipoprotein(a), an Opsonin, Enhances the Phagocytosis of Nontypeable Haemophilus influenzae by Macrophages

open access: yesJournal of Immunology Research, 2021
We recently showed that both nontypeable Haemophilus influenzae (NTHi) and its surface plasminogen- (Plg-) binding proteins interact with lipoprotein(a) (Lp(a)) in a lysine-dependent manner.
Zhi Liu   +6 more
doaj   +3 more sources

Opsonins and Dysopsonins of Nanoparticles: Facts, Concepts, and Methodological Guidelines [PDF]

open access: yesFrontiers in Immunology, 2020
Understanding the effects mediated by a set of nanoparticle (NP)-bound host biomolecules, often indicated with the umbrella term of NP corona, is essential in nanomedicine, nanopharmacology, and nanotoxicology.
Emanuele Papini   +4 more
doaj   +3 more sources

Neutrophil Elastase and Chronic Lung Disease

open access: yesBiomolecules, 2021
Neutrophil elastase (NE) is a major inflammatory protease released by neutrophils and is present in the airways of patients with cystic fibrosis (CF), chronic obstructive pulmonary disease, non-CF bronchiectasis, and bronchopulmonary dysplasia.
Judith A. Voynow, Meagan Shinbashi
doaj   +2 more sources

PEGylated Strontium Sulfite Nanoparticles with Spontaneously Formed Surface-Embedded Protein Corona Restrict Off-Target Distribution and Accelerate Breast Tumour-Selective Delivery of siRNA [PDF]

open access: yesJournal of Functional Biomaterials, 2022
As transporters of RNAi therapeutics in preclinical and clinical studies, the application of nanoparticles is often hindered by their susceptibility to opsonin-mediated clearance, poor biological stability, ineffectual targeting, and undesirable effects ...
Md. Emranul Karim   +1 more
doaj   +2 more sources

The protein corona modulates the inflammation inhibition by cationic nanoparticles via cell-free DNA scavenging

open access: yesBioactive Materials, 2022
A central paradigm in nanomedicine is that when synthetic nanoparticles (NPs) enter the body, they are immediately cloaked by a corona of macromolecules (mostly proteins) that mediates the role of the physico-chemical properties in the NP biological ...
Xingliang Liu   +6 more
doaj   +2 more sources

Protective role of Galectin-3 in prion disease through regulation of microglial PrP<sup>Sc</sup> uptake. [PDF]

open access: yesBrain Pathol
Galectin‐3 (Gal3) is induced in reactive microglia during prion disease and promotes microglial uptake of PrPSc. Gal3 deficiency reduces prion sequestration and accelerates disease progression, revealing a protective role for Gal3. Abstract Microglia constitute a major innate defense mechanism against prion infection; however, the molecular pathways ...
Makarava N   +8 more
europepmc   +2 more sources

Complement evasion factor (CEF), a novel immune evasion factor of Streptococcus pyogenes

open access: yesVirulence, 2022
Streptococcus pyogenes, a leading human pathogen, is responsible for a wide range of diseases, including skin and soft tissue infections and severe invasive diseases. S.
Haniyeh Aghababa   +5 more
doaj   +1 more source

Galectin-3 (MAC-2) controls phagocytosis and macropinocytosis through intracellular and extracellular mechanisms

open access: yesFrontiers in Cellular Neuroscience, 2022
Galectin-3 (Gal-3; formally named MAC-2) is a β-galactoside-binding lectin. Various cell types produce Gal-3 under either normal conditions and/or pathological conditions. Gal-3 can be present in cells' nuclei and cytoplasm, secreted from producing cells,
Shlomo Rotshenker
doaj   +1 more source

A C1q domain containing protein from scallop Chlamys farreri serving as pattern recognition receptor with heat-aggregated IgG binding activity. [PDF]

open access: yesPLoS ONE, 2012
BACKGROUND: The C1q domain containing (C1qDC) proteins refer to a family of all proteins that contain the globular C1q (gC1q) domain, and participate in a series of immune responses depending on their gC1q domains to bind a variety of self and non-self ...
Leilei Wang   +5 more
doaj   +1 more source

Microbes bind complement inhibitor factor H via a common site. [PDF]

open access: yesPLoS Pathogens, 2013
To cause infections microbes need to evade host defense systems, one of these being the evolutionarily old and important arm of innate immunity, the alternative pathway of complement. It can attack all kinds of targets and is tightly controlled in plasma
T Meri   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy